Clinical trial
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
NCT01979679 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
- Lead sponsor
- University of California, Irvine
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2008
- Completion date
- Not reported
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.